InterCure Shareholders Approve All Proposals at 2025 Annual Meeting
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Intercure ( (IL:INCR) ) just unveiled an announcement.
On December 30, 2025, InterCure Ltd. held its Annual General Meeting of Shareholders in which investors approved all four proposals presented on the agenda, each receiving the requisite majority. The resolutions, previously detailed in proxy materials circulated on November 25, 2025, reinforce the company’s existing governance and strategic direction, signaling broad shareholder support for management and the board’s plans going into the next fiscal year.
The most recent analyst rating on (IL:INCR) stock is a Hold with a ILs444.00 price target. To see the full list of analyst forecasts on Intercure stock, see the IL:INCR Stock Forecast page.
More about Intercure
InterCure Ltd. is an Israel-based company listed in the United States as a foreign private issuer, reporting under Form 20-F and subject to U.S. securities regulations. The company is headquartered in Herzliya, Israel, and its shares are held by an international shareholder base that participates in its annual general meetings and corporate governance processes.
Average Trading Volume: 96,228
Technical Sentiment Signal: Sell
Current Market Cap: ILs197.7M
For detailed information about INCR stock, go to TipRanks’ Stock Analysis page.
